AF
IPSC icon

Amalgamated Financial’s Century Therapeutics IPSC Stock Holding History

Amalgamated Financial’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$22K Buy
+1,720
New +$22.8K ﹤0.01% 2716

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Amalgamated Financial's IPSC Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Century Therapeutics (IPSC) in Q1 2022: 1,720 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #2716 among its holdings.

52 funds tracked by Wall St. Rank hold IPSC as of Q1 2022.

  • Amalgamated Financial held 1,720 shares of Century Therapeutics worth $22K as of Q1 2022.
  • Century Therapeutics was a new Amalgamated Financial position in Q1 2022.
  • Century Therapeutics made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2716 holding.
  • 52 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.